Drug regulators in the U.S., Canada and Australia simultaneously approved Merck's Keytruda and Eisai's Lenvima for advanced endometrial carcinoma following a collaborative review under a program called Project Orbis.
March 31, 2019, is the date by which all companies that are currently 13485 certified need to have transitioned to the 2016 regulations. Here's a checklist of what medical device companies need to do to comply.
Explore top PTSD treatment centers in Arizona, offering personalized care, holistic therapies and expert support to help individuals heal and reclaim their lives.
From the EU MDR/IVDR being revised to the MDSAP program going live, regulatory changes have been rampant and significant for medical device professionals.